Market Report, "Myocardial Infarction - Pipeline Review, H2 2012", Published
Global Markets Direct's, 'Myocardial Infarction - Pipeline Review, H2 2012', provides an overview of the Myocardial Infarction therapeutic pipeline. This report provides information on the therapeutic development for Myocardial Infarction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Myocardial Infarction. 'Myocardial Infarction - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor...
View full press release